vs
Priority Technology Holdings, Inc.（PRTH）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Priority Technology Holdings, Inc.的季度营收约是再鼎医药的1.9倍（$247.1M vs $127.1M），再鼎医药同比增速更快（17.1% vs 8.8%），Priority Technology Holdings, Inc.自由现金流更多（$30.9M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 9.6%）
Priority Technology Holdings, Inc.是一家聚焦信息技术领域的企业，业务围绕计算机、通信系统等相关信息设备展开，涵盖信息的创建、处理、存储、检索与传输等相关信息技术应用服务，依托计算机科学与工程技术支撑业务开展。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PRTH vs ZLAB — 直观对比
营收规模更大
PRTH
是对方的1.9倍
$127.1M
营收增速更快
ZLAB
高出8.3%
8.8%
自由现金流更多
PRTH
多$57.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
9.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $247.1M | $127.1M |
| 净利润 | $8.9M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 13.6% | -54.6% |
| 净利率 | 3.6% | — |
| 营收同比 | 8.8% | 17.1% |
| 净利润同比 | 23.9% | — |
| 每股收益（稀释后） | $0.10 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRTHZLAB
| Q4 25 | $247.1M | $127.1M | ||
| Q3 25 | $241.4M | $115.4M | ||
| Q2 25 | $239.8M | $109.1M | ||
| Q1 25 | $224.6M | $105.7M | ||
| Q4 24 | $227.1M | $108.5M | ||
| Q3 24 | $227.0M | $101.8M | ||
| Q2 24 | $219.9M | $100.1M | ||
| Q1 24 | $205.7M | $87.1M |
净利润PRTHZLAB
| Q4 25 | $8.9M | — | ||
| Q3 25 | $27.6M | $-36.0M | ||
| Q2 25 | $10.9M | $-40.7M | ||
| Q1 25 | $8.3M | $-48.4M | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $10.6M | $-41.7M | ||
| Q2 24 | $994.0K | $-80.3M | ||
| Q1 24 | $5.2M | $-53.5M |
毛利率PRTHZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率PRTHZLAB
| Q4 25 | 13.6% | -54.6% | ||
| Q3 25 | 15.6% | -42.3% | ||
| Q2 25 | 15.6% | -50.3% | ||
| Q1 25 | 14.5% | -53.3% | ||
| Q4 24 | 15.0% | -62.6% | ||
| Q3 24 | 16.8% | -66.6% | ||
| Q2 24 | 15.1% | -76.0% | ||
| Q1 24 | 13.6% | -80.7% |
净利率PRTHZLAB
| Q4 25 | 3.6% | — | ||
| Q3 25 | 11.4% | -31.2% | ||
| Q2 25 | 4.5% | -37.3% | ||
| Q1 25 | 3.7% | -45.8% | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 4.7% | -40.9% | ||
| Q2 24 | 0.5% | -80.2% | ||
| Q1 24 | 2.5% | -61.4% |
每股收益（稀释后）PRTHZLAB
| Q4 25 | $0.10 | $-0.05 | ||
| Q3 25 | $0.34 | $-0.03 | ||
| Q2 25 | $0.14 | $-0.04 | ||
| Q1 25 | $0.10 | $-0.04 | ||
| Q4 24 | $-0.05 | $-0.09 | ||
| Q3 24 | $0.07 | $-0.04 | ||
| Q2 24 | $-0.23 | $-0.08 | ||
| Q1 24 | $-0.10 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.2M | $689.6M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $-100.4M | $715.5M |
| 总资产 | $2.4B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRTHZLAB
| Q4 25 | $77.2M | $689.6M | ||
| Q3 25 | $57.0M | $717.2M | ||
| Q2 25 | $50.6M | $732.2M | ||
| Q1 25 | $47.6M | $757.3M | ||
| Q4 24 | $58.6M | $779.7M | ||
| Q3 24 | $41.1M | $616.1M | ||
| Q2 24 | $34.6M | $630.0M | ||
| Q1 24 | $34.3M | $650.8M |
总债务PRTHZLAB
| Q4 25 | $1.0B | — | ||
| Q3 25 | $997.5M | — | ||
| Q2 25 | $917.0M | — | ||
| Q1 25 | $918.9M | — | ||
| Q4 24 | $920.9M | — | ||
| Q3 24 | $808.1M | — | ||
| Q2 24 | $809.0M | — | ||
| Q1 24 | $631.4M | — |
股东权益PRTHZLAB
| Q4 25 | $-100.4M | $715.5M | ||
| Q3 25 | $-110.3M | $759.9M | ||
| Q2 25 | $-146.1M | $791.7M | ||
| Q1 25 | $-158.3M | $810.8M | ||
| Q4 24 | $-166.8M | $840.9M | ||
| Q3 24 | $-165.8M | $667.7M | ||
| Q2 24 | $-172.1M | $704.2M | ||
| Q1 24 | $-159.9M | $762.2M |
总资产PRTHZLAB
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.0B | $1.2B | ||
| Q1 25 | $1.9B | $1.2B | ||
| Q4 24 | $1.8B | $1.2B | ||
| Q3 24 | $1.8B | $985.3M | ||
| Q2 24 | $1.7B | $987.4M | ||
| Q1 24 | $1.6B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.8M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $30.9M | $-26.7M |
| 自由现金流率自由现金流/营收 | 12.5% | -21.0% |
| 资本支出强度资本支出/营收 | 2.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | $75.1M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PRTHZLAB
| Q4 25 | $36.8M | $-26.0M | ||
| Q3 25 | $36.1M | $-32.0M | ||
| Q2 25 | $17.1M | $-31.0M | ||
| Q1 25 | $10.0M | $-61.7M | ||
| Q4 24 | $23.8M | $-55.8M | ||
| Q3 24 | $19.8M | $-26.8M | ||
| Q2 24 | $28.7M | $-42.2M | ||
| Q1 24 | $13.3M | $-90.1M |
自由现金流PRTHZLAB
| Q4 25 | $30.9M | $-26.7M | ||
| Q3 25 | $30.1M | $-35.0M | ||
| Q2 25 | $9.2M | $-33.9M | ||
| Q1 25 | $4.9M | $-63.2M | ||
| Q4 24 | $19.1M | $-58.4M | ||
| Q3 24 | $14.5M | $-28.2M | ||
| Q2 24 | $23.6M | $-42.9M | ||
| Q1 24 | $6.7M | $-91.1M |
自由现金流率PRTHZLAB
| Q4 25 | 12.5% | -21.0% | ||
| Q3 25 | 12.5% | -30.4% | ||
| Q2 25 | 3.8% | -31.1% | ||
| Q1 25 | 2.2% | -59.9% | ||
| Q4 24 | 8.4% | -53.8% | ||
| Q3 24 | 6.4% | -27.7% | ||
| Q2 24 | 10.7% | -42.9% | ||
| Q1 24 | 3.3% | -104.5% |
资本支出强度PRTHZLAB
| Q4 25 | 2.4% | 0.5% | ||
| Q3 25 | 2.5% | 2.6% | ||
| Q2 25 | 3.3% | 2.6% | ||
| Q1 25 | 2.3% | 1.5% | ||
| Q4 24 | 2.0% | 2.4% | ||
| Q3 24 | 2.3% | 1.3% | ||
| Q2 24 | 2.3% | 0.7% | ||
| Q1 24 | 3.2% | 1.1% |
现金转化率PRTHZLAB
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 28.87× | — | ||
| Q1 24 | 2.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRTH
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
